Moss Genomics Advances Blockchain Integration Strategy

Core Viewpoint - Moss Genomics Inc. is advancing its Ethereum Treasury Strategy by contributing 200 ETH and committing to an additional 800 ETH for the presale of STRAT, a smart contract aimed at facilitating ETH-based capital flows [1][3] Group 1: Ethereum Treasury Strategy - The company has contributed 200 ETH and plans to contribute an additional 800 ETH to the STRAT presale, which targets a total of 6,900 ETH from strategic investors [1][3] - The STRAT contract operates without intermediaries, ensuring transparency in contributions and mechanics on the Ethereum blockchain [3] Group 2: Broader Vision and Partnerships - Moss Genomics aims to integrate blockchain infrastructure for secure genomic data management and has entered a non-binding term sheet for a strategic investment in Genomes.io, focusing on decentralized data storage and patient-owned health records [2][5] - The company's mission is to promote decentralized and privacy-preserving genomics through real-world applications in health, identity, and research [5] Group 3: Future Developments - The company is still progressing towards completing a previously announced private placement financing from February 3, 2025, with further updates to be provided [4]